DEBORAH PONTORIERO: Open Payments
NPI 1508829540 · LINWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 14 payments from 8 companies in 2025. Trend: 2023 $597 · 2024 $378 · 2025 $319
Food & beverage: $236Education: $83
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $117 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| GENZYME CORPORATION | 3 | $55 |
| Amgen Inc. | 1 | $19 |
| Botanix SB Inc | 1 | $18 |
| Organogenesis Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $15 |
Products named: DUPIXENT, Rhapsido, ILUMYA, COSENTYX, Otezla, SOFDRA, NUSHIELD, Sotyktu.
Industry payments across NJ — which companies pay providers there.
